NCT06433752 · Observational study
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Overall registry status Recruiting
Conditions Multiple Sclerosis, Relapsing Multiple Sclerosis
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Cherry Hill, NJ · Camden County · Recruiting
First posted
Registry updated
Added to the directory